nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—ADRB1—coronary artery disease	0.176	0.543	CbGaD
Metipranolol—ADRB2—coronary artery disease	0.148	0.457	CbGaD
Metipranolol—Oxprenolol—Penbutolol—coronary artery disease	0.11	0.391	CrCrCtD
Metipranolol—Alprenolol—Penbutolol—coronary artery disease	0.11	0.391	CrCrCtD
Metipranolol—ADRB2—Penbutolol—coronary artery disease	0.0796	0.296	CbGbCtD
Metipranolol—ADRB1—Penbutolol—coronary artery disease	0.0784	0.291	CbGbCtD
Metipranolol—Propranolol—Penbutolol—coronary artery disease	0.0617	0.218	CrCrCtD
Metipranolol—ADRB2—Timolol—coronary artery disease	0.0561	0.208	CbGbCtD
Metipranolol—ADRB1—Timolol—coronary artery disease	0.0552	0.205	CbGbCtD
Metipranolol—Practolol—ADRB1—coronary artery disease	0.000307	0.108	CrCbGaD
Metipranolol—Esmolol—ADRB1—coronary artery disease	0.000221	0.0774	CrCbGaD
Metipranolol—Atenolol—ADRB1—coronary artery disease	0.000193	0.0675	CrCbGaD
Metipranolol—Esmolol—ADRB2—coronary artery disease	0.000186	0.0651	CrCbGaD
Metipranolol—Acebutolol—ADRB1—coronary artery disease	0.000178	0.0623	CrCbGaD
Metipranolol—Oxprenolol—ADRB1—coronary artery disease	0.000176	0.0619	CrCbGaD
Metipranolol—Atenolol—ADRB2—coronary artery disease	0.000162	0.0568	CrCbGaD
Metipranolol—Alprenolol—ADRB1—coronary artery disease	0.000161	0.0566	CrCbGaD
Metipranolol—Metoprolol—ADRB1—coronary artery disease	0.00015	0.0526	CrCbGaD
Metipranolol—Acebutolol—ADRB2—coronary artery disease	0.000149	0.0524	CrCbGaD
Metipranolol—Oxprenolol—ADRB2—coronary artery disease	0.000148	0.052	CrCbGaD
Metipranolol—Rash—Gemfibrozil—coronary artery disease	0.000144	0.00161	CcSEcCtD
Metipranolol—Oedema—Pravastatin—coronary artery disease	0.000144	0.00161	CcSEcCtD
Metipranolol—Dermatitis—Gemfibrozil—coronary artery disease	0.000144	0.00161	CcSEcCtD
Metipranolol—Rhinitis—Timolol—coronary artery disease	0.000144	0.00161	CcSEcCtD
Metipranolol—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000144	0.00161	CcSEcCtD
Metipranolol—Discomfort—Enalapril—coronary artery disease	0.000143	0.00161	CcSEcCtD
Metipranolol—Myalgia—Telmisartan—coronary artery disease	0.000143	0.0016	CcSEcCtD
Metipranolol—Headache—Gemfibrozil—coronary artery disease	0.000143	0.0016	CcSEcCtD
Metipranolol—Cough—Captopril—coronary artery disease	0.000143	0.0016	CcSEcCtD
Metipranolol—Anxiety—Telmisartan—coronary artery disease	0.000143	0.0016	CcSEcCtD
Metipranolol—Dyspnoea—Simvastatin—coronary artery disease	0.000142	0.00159	CcSEcCtD
Metipranolol—Discomfort—Telmisartan—coronary artery disease	0.000141	0.00158	CcSEcCtD
Metipranolol—Visual impairment—Ramipril—coronary artery disease	0.000141	0.00158	CcSEcCtD
Metipranolol—Rash—Ticagrelor—coronary artery disease	0.000141	0.00157	CcSEcCtD
Metipranolol—Dermatitis—Ticagrelor—coronary artery disease	0.000141	0.00157	CcSEcCtD
Metipranolol—Vision blurred—Losartan—coronary artery disease	0.00014	0.00157	CcSEcCtD
Metipranolol—Palpitations—Perindopril—coronary artery disease	0.00014	0.00157	CcSEcCtD
Metipranolol—Epistaxis—Lisinopril—coronary artery disease	0.00014	0.00156	CcSEcCtD
Metipranolol—Headache—Ticagrelor—coronary artery disease	0.00014	0.00156	CcSEcCtD
Metipranolol—Oedema—Trandolapril—coronary artery disease	0.00014	0.00156	CcSEcCtD
Metipranolol—Myalgia—Captopril—coronary artery disease	0.000139	0.00156	CcSEcCtD
Metipranolol—Oedema—Enalapril—coronary artery disease	0.000139	0.00156	CcSEcCtD
Metipranolol—Pindolol—ADRB1—coronary artery disease	0.000139	0.0487	CrCbGaD
Metipranolol—Cough—Perindopril—coronary artery disease	0.000139	0.00155	CcSEcCtD
Metipranolol—Visual impairment—Timolol—coronary artery disease	0.000138	0.00155	CcSEcCtD
Metipranolol—Discomfort—Captopril—coronary artery disease	0.000138	0.00154	CcSEcCtD
Metipranolol—Oedema—Telmisartan—coronary artery disease	0.000137	0.00154	CcSEcCtD
Metipranolol—Hypertension—Perindopril—coronary artery disease	0.000137	0.00153	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Valsartan—coronary artery disease	0.000137	0.00153	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Olmesartan—coronary artery disease	0.000136	0.00152	CcSEcCtD
Metipranolol—Alprenolol—ADRB2—coronary artery disease	0.000136	0.0476	CrCbGaD
Metipranolol—Nausea—Gemfibrozil—coronary artery disease	0.000136	0.00152	CcSEcCtD
Metipranolol—Bradycardia—Lisinopril—coronary artery disease	0.000135	0.00152	CcSEcCtD
Metipranolol—Myalgia—Perindopril—coronary artery disease	0.000135	0.00151	CcSEcCtD
Metipranolol—Anxiety—Perindopril—coronary artery disease	0.000135	0.00151	CcSEcCtD
Metipranolol—Dyspnoea—Valsartan—coronary artery disease	0.000134	0.0015	CcSEcCtD
Metipranolol—Somnolence—Valsartan—coronary artery disease	0.000134	0.0015	CcSEcCtD
Metipranolol—Discomfort—Perindopril—coronary artery disease	0.000134	0.00149	CcSEcCtD
Metipranolol—Rhinitis—Lisinopril—coronary artery disease	0.000133	0.00149	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Niacin—coronary artery disease	0.000133	0.00149	CcSEcCtD
Metipranolol—Dizziness—Rosuvastatin—coronary artery disease	0.000133	0.00149	CcSEcCtD
Metipranolol—Nausea—Ticagrelor—coronary artery disease	0.000133	0.00148	CcSEcCtD
Metipranolol—Palpitations—Losartan—coronary artery disease	0.000132	0.00147	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Pravastatin—coronary artery disease	0.000131	0.00147	CcSEcCtD
Metipranolol—Dyspnoea—Niacin—coronary artery disease	0.00013	0.00146	CcSEcCtD
Metipranolol—Cough—Losartan—coronary artery disease	0.00013	0.00145	CcSEcCtD
Metipranolol—Somnolence—Niacin—coronary artery disease	0.00013	0.00145	CcSEcCtD
Metipranolol—Oedema—Perindopril—coronary artery disease	0.00013	0.00145	CcSEcCtD
Metipranolol—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000129	0.00144	CcSEcCtD
Metipranolol—Hypersensitivity—Fenofibrate—coronary artery disease	0.000128	0.00144	CcSEcCtD
Metipranolol—Dyspnoea—Pravastatin—coronary artery disease	0.000128	0.00144	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000127	0.00142	CcSEcCtD
Metipranolol—Myalgia—Losartan—coronary artery disease	0.000127	0.00142	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000127	0.00142	CcSEcCtD
Metipranolol—Rash—Rosuvastatin—coronary artery disease	0.000127	0.00142	CcSEcCtD
Metipranolol—Dermatitis—Rosuvastatin—coronary artery disease	0.000126	0.00142	CcSEcCtD
Metipranolol—Anxiety—Losartan—coronary artery disease	0.000126	0.00141	CcSEcCtD
Metipranolol—Hypersensitivity—Clopidogrel—coronary artery disease	0.000126	0.00141	CcSEcCtD
Metipranolol—Metoprolol—ADRB2—coronary artery disease	0.000126	0.0442	CrCbGaD
Metipranolol—Headache—Rosuvastatin—coronary artery disease	0.000126	0.00141	CcSEcCtD
Metipranolol—Hypersensitivity—Lovastatin—coronary artery disease	0.000125	0.0014	CcSEcCtD
Metipranolol—Tension—Ramipril—coronary artery disease	0.000125	0.0014	CcSEcCtD
Metipranolol—Discomfort—Losartan—coronary artery disease	0.000125	0.0014	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000125	0.0014	CcSEcCtD
Metipranolol—Asthenia—Fenofibrate—coronary artery disease	0.000125	0.0014	CcSEcCtD
Metipranolol—Dyspnoea—Trandolapril—coronary artery disease	0.000125	0.00139	CcSEcCtD
Metipranolol—Somnolence—Trandolapril—coronary artery disease	0.000124	0.00139	CcSEcCtD
Metipranolol—Dyspnoea—Enalapril—coronary artery disease	0.000124	0.00139	CcSEcCtD
Metipranolol—Nervousness—Ramipril—coronary artery disease	0.000124	0.00139	CcSEcCtD
Metipranolol—Somnolence—Enalapril—coronary artery disease	0.000124	0.00138	CcSEcCtD
Metipranolol—Rash—Acetylsalicylic acid—coronary artery disease	0.000123	0.00138	CcSEcCtD
Metipranolol—Hypersensitivity—Ezetimibe—coronary artery disease	0.000123	0.00138	CcSEcCtD
Metipranolol—Asthenia—Clopidogrel—coronary artery disease	0.000123	0.00138	CcSEcCtD
Metipranolol—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000123	0.00137	CcSEcCtD
Metipranolol—Tension—Timolol—coronary artery disease	0.000123	0.00137	CcSEcCtD
Metipranolol—Dyspnoea—Telmisartan—coronary artery disease	0.000122	0.00137	CcSEcCtD
Metipranolol—Asthenia—Lovastatin—coronary artery disease	0.000122	0.00137	CcSEcCtD
Metipranolol—Somnolence—Telmisartan—coronary artery disease	0.000122	0.00137	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000122	0.00136	CcSEcCtD
Metipranolol—Oedema—Losartan—coronary artery disease	0.000122	0.00136	CcSEcCtD
Metipranolol—Nervousness—Timolol—coronary artery disease	0.000121	0.00136	CcSEcCtD
Metipranolol—Asthenia—Ezetimibe—coronary artery disease	0.00012	0.00134	CcSEcCtD
Metipranolol—Nausea—Rosuvastatin—coronary artery disease	0.000119	0.00133	CcSEcCtD
Metipranolol—Dyspnoea—Captopril—coronary artery disease	0.000119	0.00133	CcSEcCtD
Metipranolol—Somnolence—Captopril—coronary artery disease	0.000119	0.00133	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000118	0.00132	CcSEcCtD
Metipranolol—Vision blurred—Timolol—coronary artery disease	0.000118	0.00132	CcSEcCtD
Metipranolol—Hypersensitivity—Simvastatin—coronary artery disease	0.000117	0.00131	CcSEcCtD
Metipranolol—Asthenia—Eplerenone—coronary artery disease	0.000117	0.00131	CcSEcCtD
Metipranolol—Pindolol—ADRB2—coronary artery disease	0.000117	0.0409	CrCbGaD
Metipranolol—Nausea—Acetylsalicylic acid—coronary artery disease	0.000116	0.0013	CcSEcCtD
Metipranolol—Dyspnoea—Perindopril—coronary artery disease	0.000116	0.00129	CcSEcCtD
Metipranolol—Dizziness—Fenofibrate—coronary artery disease	0.000115	0.00129	CcSEcCtD
Metipranolol—Somnolence—Perindopril—coronary artery disease	0.000115	0.00129	CcSEcCtD
Metipranolol—Asthenia—Simvastatin—coronary artery disease	0.000114	0.00128	CcSEcCtD
Metipranolol—Tension—Lisinopril—coronary artery disease	0.000114	0.00127	CcSEcCtD
Metipranolol—Dizziness—Clopidogrel—coronary artery disease	0.000113	0.00127	CcSEcCtD
Metipranolol—Palpitations—Ramipril—coronary artery disease	0.000113	0.00126	CcSEcCtD
Metipranolol—Dizziness—Lovastatin—coronary artery disease	0.000113	0.00126	CcSEcCtD
Metipranolol—Nervousness—Lisinopril—coronary artery disease	0.000113	0.00126	CcSEcCtD
Metipranolol—Somnolence—Furosemide—coronary artery disease	0.000112	0.00125	CcSEcCtD
Metipranolol—Cough—Ramipril—coronary artery disease	0.000111	0.00125	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000111	0.00124	CcSEcCtD
Metipranolol—Hypersensitivity—Valsartan—coronary artery disease	0.000111	0.00124	CcSEcCtD
Metipranolol—Dizziness—Ezetimibe—coronary artery disease	0.00011	0.00123	CcSEcCtD
Metipranolol—Palpitations—Timolol—coronary artery disease	0.00011	0.00123	CcSEcCtD
Metipranolol—Rash—Fenofibrate—coronary artery disease	0.00011	0.00123	CcSEcCtD
Metipranolol—Dermatitis—Fenofibrate—coronary artery disease	0.00011	0.00123	CcSEcCtD
Metipranolol—Headache—Fenofibrate—coronary artery disease	0.000109	0.00122	CcSEcCtD
Metipranolol—Vision blurred—Lisinopril—coronary artery disease	0.000109	0.00122	CcSEcCtD
Metipranolol—Cough—Timolol—coronary artery disease	0.000109	0.00122	CcSEcCtD
Metipranolol—Myalgia—Ramipril—coronary artery disease	0.000109	0.00122	CcSEcCtD
Metipranolol—Metoprolol—CYP2C19—coronary artery disease	0.000109	0.0381	CrCbGaD
Metipranolol—Dyspnoea—Losartan—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Anxiety—Ramipril—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Somnolence—Losartan—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Dizziness—Eplerenone—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Rash—Clopidogrel—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Dermatitis—Clopidogrel—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Asthenia—Valsartan—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Hypertension—Timolol—coronary artery disease	0.000108	0.00121	CcSEcCtD
Metipranolol—Hypersensitivity—Niacin—coronary artery disease	0.000108	0.0012	CcSEcCtD
Metipranolol—Discomfort—Ramipril—coronary artery disease	0.000107	0.0012	CcSEcCtD
Metipranolol—Asthenia—Olmesartan—coronary artery disease	0.000107	0.0012	CcSEcCtD
Metipranolol—Headache—Clopidogrel—coronary artery disease	0.000107	0.0012	CcSEcCtD
Metipranolol—Rash—Lovastatin—coronary artery disease	0.000107	0.0012	CcSEcCtD
Metipranolol—Dermatitis—Lovastatin—coronary artery disease	0.000107	0.0012	CcSEcCtD
Metipranolol—Headache—Lovastatin—coronary artery disease	0.000107	0.00119	CcSEcCtD
Metipranolol—Myalgia—Timolol—coronary artery disease	0.000106	0.00119	CcSEcCtD
Metipranolol—Hypersensitivity—Pravastatin—coronary artery disease	0.000106	0.00119	CcSEcCtD
Metipranolol—Anxiety—Timolol—coronary artery disease	0.000106	0.00119	CcSEcCtD
Metipranolol—Dizziness—Simvastatin—coronary artery disease	0.000105	0.00118	CcSEcCtD
Metipranolol—Rash—Ezetimibe—coronary artery disease	0.000105	0.00118	CcSEcCtD
Metipranolol—Dermatitis—Ezetimibe—coronary artery disease	0.000105	0.00118	CcSEcCtD
Metipranolol—Discomfort—Timolol—coronary artery disease	0.000105	0.00118	CcSEcCtD
Metipranolol—Asthenia—Niacin—coronary artery disease	0.000105	0.00117	CcSEcCtD
Metipranolol—Headache—Ezetimibe—coronary artery disease	0.000105	0.00117	CcSEcCtD
Metipranolol—Oedema—Ramipril—coronary artery disease	0.000104	0.00117	CcSEcCtD
Metipranolol—Nausea—Fenofibrate—coronary artery disease	0.000104	0.00116	CcSEcCtD
Metipranolol—Asthenia—Pravastatin—coronary artery disease	0.000103	0.00116	CcSEcCtD
Metipranolol—Rash—Eplerenone—coronary artery disease	0.000103	0.00115	CcSEcCtD
Metipranolol—Hypersensitivity—Trandolapril—coronary artery disease	0.000103	0.00115	CcSEcCtD
Metipranolol—Dermatitis—Eplerenone—coronary artery disease	0.000103	0.00115	CcSEcCtD
Metipranolol—Hypersensitivity—Enalapril—coronary artery disease	0.000103	0.00115	CcSEcCtD
Metipranolol—Palpitations—Lisinopril—coronary artery disease	0.000102	0.00115	CcSEcCtD
Metipranolol—Headache—Eplerenone—coronary artery disease	0.000102	0.00115	CcSEcCtD
Metipranolol—Oedema—Timolol—coronary artery disease	0.000102	0.00114	CcSEcCtD
Metipranolol—Nausea—Clopidogrel—coronary artery disease	0.000102	0.00114	CcSEcCtD
Metipranolol—Hypersensitivity—Telmisartan—coronary artery disease	0.000101	0.00113	CcSEcCtD
Metipranolol—Cough—Lisinopril—coronary artery disease	0.000101	0.00113	CcSEcCtD
Metipranolol—Nausea—Lovastatin—coronary artery disease	0.000101	0.00113	CcSEcCtD
Metipranolol—Rash—Simvastatin—coronary artery disease	0.0001	0.00112	CcSEcCtD
Metipranolol—Dermatitis—Simvastatin—coronary artery disease	0.0001	0.00112	CcSEcCtD
Metipranolol—Asthenia—Trandolapril—coronary artery disease	0.0001	0.00112	CcSEcCtD
Metipranolol—Asthenia—Enalapril—coronary artery disease	9.99e-05	0.00112	CcSEcCtD
Metipranolol—Headache—Simvastatin—coronary artery disease	9.97e-05	0.00112	CcSEcCtD
Metipranolol—Dizziness—Valsartan—coronary artery disease	9.94e-05	0.00111	CcSEcCtD
Metipranolol—Nausea—Ezetimibe—coronary artery disease	9.91e-05	0.00111	CcSEcCtD
Metipranolol—Dizziness—Olmesartan—coronary artery disease	9.89e-05	0.00111	CcSEcCtD
Metipranolol—Myalgia—Lisinopril—coronary artery disease	9.86e-05	0.0011	CcSEcCtD
Metipranolol—Asthenia—Telmisartan—coronary artery disease	9.85e-05	0.0011	CcSEcCtD
Metipranolol—Anxiety—Lisinopril—coronary artery disease	9.83e-05	0.0011	CcSEcCtD
Metipranolol—Discomfort—Lisinopril—coronary artery disease	9.74e-05	0.00109	CcSEcCtD
Metipranolol—Nausea—Eplerenone—coronary artery disease	9.7e-05	0.00109	CcSEcCtD
Metipranolol—Dizziness—Niacin—coronary artery disease	9.66e-05	0.00108	CcSEcCtD
Metipranolol—Asthenia—Captopril—coronary artery disease	9.58e-05	0.00107	CcSEcCtD
Metipranolol—Dizziness—Pravastatin—coronary artery disease	9.52e-05	0.00106	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Ramipril—coronary artery disease	9.5e-05	0.00106	CcSEcCtD
Metipranolol—Rash—Valsartan—coronary artery disease	9.48e-05	0.00106	CcSEcCtD
Metipranolol—Dermatitis—Valsartan—coronary artery disease	9.47e-05	0.00106	CcSEcCtD
Metipranolol—Nausea—Simvastatin—coronary artery disease	9.45e-05	0.00106	CcSEcCtD
Metipranolol—Oedema—Lisinopril—coronary artery disease	9.45e-05	0.00106	CcSEcCtD
Metipranolol—Rash—Olmesartan—coronary artery disease	9.43e-05	0.00106	CcSEcCtD
Metipranolol—Dermatitis—Olmesartan—coronary artery disease	9.42e-05	0.00105	CcSEcCtD
Metipranolol—Headache—Valsartan—coronary artery disease	9.42e-05	0.00105	CcSEcCtD
Metipranolol—Headache—Olmesartan—coronary artery disease	9.37e-05	0.00105	CcSEcCtD
Metipranolol—Asthenia—Perindopril—coronary artery disease	9.3e-05	0.00104	CcSEcCtD
Metipranolol—Dyspnoea—Ramipril—coronary artery disease	9.29e-05	0.00104	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Timolol—coronary artery disease	9.28e-05	0.00104	CcSEcCtD
Metipranolol—Hypersensitivity—Furosemide—coronary artery disease	9.28e-05	0.00104	CcSEcCtD
Metipranolol—Somnolence—Ramipril—coronary artery disease	9.27e-05	0.00104	CcSEcCtD
Metipranolol—Dizziness—Trandolapril—coronary artery disease	9.24e-05	0.00103	CcSEcCtD
Metipranolol—Rash—Niacin—coronary artery disease	9.22e-05	0.00103	CcSEcCtD
Metipranolol—Dermatitis—Niacin—coronary artery disease	9.21e-05	0.00103	CcSEcCtD
Metipranolol—Dizziness—Enalapril—coronary artery disease	9.2e-05	0.00103	CcSEcCtD
Metipranolol—Headache—Niacin—coronary artery disease	9.16e-05	0.00102	CcSEcCtD
Metipranolol—Dyspnoea—Timolol—coronary artery disease	9.09e-05	0.00102	CcSEcCtD
Metipranolol—Dizziness—Telmisartan—coronary artery disease	9.08e-05	0.00102	CcSEcCtD
Metipranolol—Rash—Pravastatin—coronary artery disease	9.07e-05	0.00102	CcSEcCtD
Metipranolol—Dermatitis—Pravastatin—coronary artery disease	9.07e-05	0.00101	CcSEcCtD
Metipranolol—Somnolence—Timolol—coronary artery disease	9.06e-05	0.00101	CcSEcCtD
Metipranolol—Asthenia—Furosemide—coronary artery disease	9.04e-05	0.00101	CcSEcCtD
Metipranolol—Headache—Pravastatin—coronary artery disease	9.02e-05	0.00101	CcSEcCtD
Metipranolol—Hypersensitivity—Losartan—coronary artery disease	8.96e-05	0.001	CcSEcCtD
Metipranolol—Nausea—Valsartan—coronary artery disease	8.93e-05	0.000999	CcSEcCtD
Metipranolol—Nausea—Olmesartan—coronary artery disease	8.89e-05	0.000994	CcSEcCtD
Metipranolol—Dizziness—Captopril—coronary artery disease	8.83e-05	0.000988	CcSEcCtD
Metipranolol—Rash—Trandolapril—coronary artery disease	8.81e-05	0.000986	CcSEcCtD
Metipranolol—Dermatitis—Trandolapril—coronary artery disease	8.8e-05	0.000985	CcSEcCtD
Metipranolol—Rash—Enalapril—coronary artery disease	8.78e-05	0.000982	CcSEcCtD
Metipranolol—Dermatitis—Enalapril—coronary artery disease	8.77e-05	0.000981	CcSEcCtD
Metipranolol—Headache—Trandolapril—coronary artery disease	8.75e-05	0.00098	CcSEcCtD
Metipranolol—Asthenia—Losartan—coronary artery disease	8.72e-05	0.000976	CcSEcCtD
Metipranolol—Headache—Enalapril—coronary artery disease	8.72e-05	0.000976	CcSEcCtD
Metipranolol—Nausea—Niacin—coronary artery disease	8.68e-05	0.000971	CcSEcCtD
Metipranolol—Rash—Telmisartan—coronary artery disease	8.66e-05	0.000969	CcSEcCtD
Metipranolol—Dermatitis—Telmisartan—coronary artery disease	8.65e-05	0.000968	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.61e-05	0.000964	CcSEcCtD
Metipranolol—Headache—Telmisartan—coronary artery disease	8.6e-05	0.000962	CcSEcCtD
Metipranolol—Dizziness—Perindopril—coronary artery disease	8.57e-05	0.000959	CcSEcCtD
Metipranolol—Nausea—Pravastatin—coronary artery disease	8.55e-05	0.000956	CcSEcCtD
Metipranolol—Dyspnoea—Lisinopril—coronary artery disease	8.43e-05	0.000943	CcSEcCtD
Metipranolol—Rash—Captopril—coronary artery disease	8.42e-05	0.000942	CcSEcCtD
Metipranolol—Dermatitis—Captopril—coronary artery disease	8.41e-05	0.000941	CcSEcCtD
Metipranolol—Somnolence—Lisinopril—coronary artery disease	8.4e-05	0.00094	CcSEcCtD
Metipranolol—Headache—Captopril—coronary artery disease	8.36e-05	0.000936	CcSEcCtD
Metipranolol—Dizziness—Furosemide—coronary artery disease	8.33e-05	0.000932	CcSEcCtD
Metipranolol—Nausea—Trandolapril—coronary artery disease	8.3e-05	0.000929	CcSEcCtD
Metipranolol—Nausea—Enalapril—coronary artery disease	8.27e-05	0.000925	CcSEcCtD
Metipranolol—Rash—Perindopril—coronary artery disease	8.17e-05	0.000914	CcSEcCtD
Metipranolol—Dermatitis—Perindopril—coronary artery disease	8.16e-05	0.000914	CcSEcCtD
Metipranolol—Nausea—Telmisartan—coronary artery disease	8.15e-05	0.000912	CcSEcCtD
Metipranolol—Headache—Perindopril—coronary artery disease	8.12e-05	0.000909	CcSEcCtD
Metipranolol—Dizziness—Losartan—coronary artery disease	8.04e-05	0.0009	CcSEcCtD
Metipranolol—Rash—Furosemide—coronary artery disease	7.94e-05	0.000889	CcSEcCtD
Metipranolol—Dermatitis—Furosemide—coronary artery disease	7.94e-05	0.000888	CcSEcCtD
Metipranolol—Nausea—Captopril—coronary artery disease	7.93e-05	0.000887	CcSEcCtD
Metipranolol—Headache—Furosemide—coronary artery disease	7.89e-05	0.000883	CcSEcCtD
Metipranolol—Nausea—Perindopril—coronary artery disease	7.7e-05	0.000861	CcSEcCtD
Metipranolol—Hypersensitivity—Ramipril—coronary artery disease	7.68e-05	0.000859	CcSEcCtD
Metipranolol—Rash—Losartan—coronary artery disease	7.67e-05	0.000858	CcSEcCtD
Metipranolol—Dermatitis—Losartan—coronary artery disease	7.66e-05	0.000857	CcSEcCtD
Metipranolol—Headache—Losartan—coronary artery disease	7.62e-05	0.000852	CcSEcCtD
Metipranolol—Propranolol—ADRB1—coronary artery disease	7.57e-05	0.0265	CrCbGaD
Metipranolol—Hypersensitivity—Timolol—coronary artery disease	7.51e-05	0.00084	CcSEcCtD
Metipranolol—Nausea—Furosemide—coronary artery disease	7.48e-05	0.000837	CcSEcCtD
Metipranolol—Asthenia—Ramipril—coronary artery disease	7.48e-05	0.000837	CcSEcCtD
Metipranolol—Asthenia—Timolol—coronary artery disease	7.31e-05	0.000818	CcSEcCtD
Metipranolol—Nausea—Losartan—coronary artery disease	7.22e-05	0.000808	CcSEcCtD
Metipranolol—Hypersensitivity—Lisinopril—coronary artery disease	6.97e-05	0.000779	CcSEcCtD
Metipranolol—Dizziness—Ramipril—coronary artery disease	6.89e-05	0.000771	CcSEcCtD
Metipranolol—Asthenia—Lisinopril—coronary artery disease	6.78e-05	0.000759	CcSEcCtD
Metipranolol—Dizziness—Timolol—coronary artery disease	6.74e-05	0.000754	CcSEcCtD
Metipranolol—Rash—Ramipril—coronary artery disease	6.57e-05	0.000735	CcSEcCtD
Metipranolol—Dermatitis—Ramipril—coronary artery disease	6.57e-05	0.000735	CcSEcCtD
Metipranolol—Headache—Ramipril—coronary artery disease	6.53e-05	0.000731	CcSEcCtD
Metipranolol—Rash—Timolol—coronary artery disease	6.43e-05	0.000719	CcSEcCtD
Metipranolol—Dermatitis—Timolol—coronary artery disease	6.42e-05	0.000718	CcSEcCtD
Metipranolol—Headache—Timolol—coronary artery disease	6.38e-05	0.000714	CcSEcCtD
Metipranolol—Propranolol—ADRB2—coronary artery disease	6.37e-05	0.0223	CrCbGaD
Metipranolol—Dizziness—Lisinopril—coronary artery disease	6.25e-05	0.000699	CcSEcCtD
Metipranolol—Nausea—Ramipril—coronary artery disease	6.19e-05	0.000693	CcSEcCtD
Metipranolol—Nausea—Timolol—coronary artery disease	6.05e-05	0.000677	CcSEcCtD
Metipranolol—Rash—Lisinopril—coronary artery disease	5.96e-05	0.000667	CcSEcCtD
Metipranolol—Dermatitis—Lisinopril—coronary artery disease	5.96e-05	0.000666	CcSEcCtD
Metipranolol—Headache—Lisinopril—coronary artery disease	5.92e-05	0.000663	CcSEcCtD
Metipranolol—Nausea—Lisinopril—coronary artery disease	5.62e-05	0.000628	CcSEcCtD
Metipranolol—Propranolol—CYP2C19—coronary artery disease	5.48e-05	0.0192	CrCbGaD
Metipranolol—ADRB2—Signaling Pathways—BDKRB1—coronary artery disease	1.21e-05	0.000377	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—P4HB—coronary artery disease	1.21e-05	0.000377	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GNA12—coronary artery disease	1.21e-05	0.000377	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CX3CL1—coronary artery disease	1.21e-05	0.000377	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADM—coronary artery disease	1.21e-05	0.000375	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCE—coronary artery disease	1.21e-05	0.000374	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—EDN1—coronary artery disease	1.2e-05	0.000373	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CSF2—coronary artery disease	1.2e-05	0.000373	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CCL5—coronary artery disease	1.19e-05	0.00037	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PPP3R1—coronary artery disease	1.19e-05	0.00037	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADM—coronary artery disease	1.18e-05	0.000366	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PDE4B—coronary artery disease	1.18e-05	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CYBB—coronary artery disease	1.18e-05	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CXCL8—coronary artery disease	1.17e-05	0.000365	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CSF2—coronary artery disease	1.17e-05	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—MMP3—coronary artery disease	1.17e-05	0.000364	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PDE4B—coronary artery disease	1.15e-05	0.000357	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CYBB—coronary artery disease	1.15e-05	0.000357	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CXCL8—coronary artery disease	1.15e-05	0.000357	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—MMP3—coronary artery disease	1.15e-05	0.000356	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—EDN1—coronary artery disease	1.12e-05	0.000346	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCL5—coronary artery disease	1.11e-05	0.000344	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PRKCD—coronary artery disease	1.1e-05	0.000341	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—EDN1—coronary artery disease	1.09e-05	0.000339	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CSF2—coronary artery disease	1.09e-05	0.000339	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCL5—coronary artery disease	1.08e-05	0.000336	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR3—coronary artery disease	1.08e-05	0.000334	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—coronary artery disease	1.07e-05	0.000334	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PRKCD—coronary artery disease	1.07e-05	0.000334	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—C3—coronary artery disease	1.07e-05	0.000333	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CSF2—coronary artery disease	1.07e-05	0.000331	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CRK—coronary artery disease	1.06e-05	0.00033	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR3—coronary artery disease	1.05e-05	0.000327	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—coronary artery disease	1.05e-05	0.000326	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—C3—coronary artery disease	1.05e-05	0.000326	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SH2B3—coronary artery disease	1.05e-05	0.000325	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—VWF—coronary artery disease	1.05e-05	0.000325	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ATP2A2—coronary artery disease	1.05e-05	0.000325	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOC3—coronary artery disease	1.04e-05	0.000323	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CRK—coronary artery disease	1.04e-05	0.000322	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LDLR—coronary artery disease	1.03e-05	0.000321	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SH2B3—coronary artery disease	1.02e-05	0.000318	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—VWF—coronary artery disease	1.02e-05	0.000318	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ATP2A2—coronary artery disease	1.02e-05	0.000318	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AGT—coronary artery disease	1.02e-05	0.000317	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOC3—coronary artery disease	1.02e-05	0.000316	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PPP2CA—coronary artery disease	1.02e-05	0.000315	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LDLR—coronary artery disease	1.01e-05	0.000314	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CXCL2—coronary artery disease	1.01e-05	0.000314	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL3—coronary artery disease	1.01e-05	0.000314	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SDC1—coronary artery disease	9.99e-06	0.00031	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—F2R—coronary artery disease	9.99e-06	0.00031	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AGT—coronary artery disease	9.97e-06	0.00031	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PRKCD—coronary artery disease	9.97e-06	0.00031	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PPP2CA—coronary artery disease	9.93e-06	0.000309	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CXCL2—coronary artery disease	9.89e-06	0.000307	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL3—coronary artery disease	9.89e-06	0.000307	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FGB—coronary artery disease	9.78e-06	0.000304	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SDC1—coronary artery disease	9.78e-06	0.000304	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—F2R—coronary artery disease	9.78e-06	0.000304	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—coronary artery disease	9.76e-06	0.000303	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCD—coronary artery disease	9.75e-06	0.000303	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—C3—coronary artery disease	9.74e-06	0.000303	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EDNRB—coronary artery disease	9.68e-06	0.000301	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FGB—coronary artery disease	9.57e-06	0.000297	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—coronary artery disease	9.55e-06	0.000296	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—THBS1—coronary artery disease	9.53e-06	0.000296	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—C3—coronary artery disease	9.53e-06	0.000296	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EDNRB—coronary artery disease	9.47e-06	0.000294	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PSMB5—coronary artery disease	9.44e-06	0.000293	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PSMA6—coronary artery disease	9.44e-06	0.000293	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—F2—coronary artery disease	9.42e-06	0.000293	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—THBS1—coronary artery disease	9.33e-06	0.00029	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AGT—coronary artery disease	9.26e-06	0.000288	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PSMA6—coronary artery disease	9.24e-06	0.000287	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PSMB5—coronary artery disease	9.24e-06	0.000287	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—F2—coronary artery disease	9.22e-06	0.000286	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EDNRA—coronary artery disease	9.14e-06	0.000284	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CYBA—coronary artery disease	9.1e-06	0.000283	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DUSP6—coronary artery disease	9.06e-06	0.000281	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AGT—coronary artery disease	9.06e-06	0.000281	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EDNRA—coronary artery disease	8.94e-06	0.000278	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLAT—coronary artery disease	8.91e-06	0.000277	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADRB1—coronary artery disease	8.9e-06	0.000277	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CYBA—coronary artery disease	8.9e-06	0.000277	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DUSP6—coronary artery disease	8.86e-06	0.000275	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLAT—coronary artery disease	8.71e-06	0.000271	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CXCL12—coronary artery disease	8.59e-06	0.000267	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—BDKRB2—coronary artery disease	8.59e-06	0.000267	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—POMC—coronary artery disease	8.58e-06	0.000267	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—F2—coronary artery disease	8.55e-06	0.000266	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	8.52e-06	0.000265	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	8.44e-06	0.000262	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	8.41e-06	0.000261	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	8.41e-06	0.000261	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	8.41e-06	0.000261	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	8.39e-06	0.000261	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—F2—coronary artery disease	8.37e-06	0.00026	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	8.33e-06	0.000259	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	8.25e-06	0.000256	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	8.23e-06	0.000256	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	8.22e-06	0.000255	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	8.05e-06	0.00025	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	7.84e-06	0.000244	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	7.82e-06	0.000243	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	7.79e-06	0.000242	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	7.79e-06	0.000242	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	7.77e-06	0.000241	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	7.67e-06	0.000238	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	7.65e-06	0.000238	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	7.62e-06	0.000237	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	7.62e-06	0.000237	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	7.62e-06	0.000237	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	7.6e-06	0.000236	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	7.6e-06	0.000236	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	7.6e-06	0.000236	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLG—coronary artery disease	7.57e-06	0.000235	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	7.46e-06	0.000232	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	7.44e-06	0.000231	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	7.43e-06	0.000231	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	7.41e-06	0.00023	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	7.37e-06	0.000229	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	7.28e-06	0.000226	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	7.27e-06	0.000226	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	7.26e-06	0.000226	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	7.24e-06	0.000225	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	7.17e-06	0.000223	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	7.12e-06	0.000221	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	7.11e-06	0.000221	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	7.1e-06	0.000221	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	7.09e-06	0.00022	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	7.09e-06	0.00022	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	7.09e-06	0.00022	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	7.02e-06	0.000218	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	6.93e-06	0.000215	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	6.93e-06	0.000215	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	6.93e-06	0.000215	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	6.93e-06	0.000215	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	6.78e-06	0.00021	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	6.78e-06	0.00021	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	6.7e-06	0.000208	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	6.64e-06	0.000206	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	6.6e-06	0.000205	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	6.59e-06	0.000205	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	6.55e-06	0.000203	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	6.54e-06	0.000203	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	6.49e-06	0.000202	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	6.46e-06	0.000201	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	6.45e-06	0.0002	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	6.44e-06	0.0002	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	6.44e-06	0.0002	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	6.4e-06	0.000199	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	6.39e-06	0.000199	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	6.34e-06	0.000197	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	6.34e-06	0.000197	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	6.3e-06	0.000196	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	6.3e-06	0.000196	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	6.25e-06	0.000194	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	6.2e-06	0.000193	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	6.2e-06	0.000193	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	6.17e-06	0.000192	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	6.04e-06	0.000188	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	6.03e-06	0.000187	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	6e-06	0.000186	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	5.9e-06	0.000183	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	5.89e-06	0.000183	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	5.87e-06	0.000182	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	5.76e-06	0.000179	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	5.76e-06	0.000179	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—C3—coronary artery disease	5.76e-06	0.000179	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	5.64e-06	0.000175	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—C3—coronary artery disease	5.63e-06	0.000175	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	5.49e-06	0.000171	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	5.47e-06	0.00017	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	5.37e-06	0.000167	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	5.36e-06	0.000166	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	5.36e-06	0.000166	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	5.35e-06	0.000166	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	5.3e-06	0.000165	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	5.25e-06	0.000163	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	5.24e-06	0.000163	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	5.24e-06	0.000163	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	5.22e-06	0.000162	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	5.18e-06	0.000161	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	5.14e-06	0.00016	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	5.12e-06	0.000159	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	5.1e-06	0.000158	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	5.05e-06	0.000157	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—F2—coronary artery disease	5.05e-06	0.000157	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	5.03e-06	0.000156	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	5e-06	0.000155	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	4.99e-06	0.000155	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	4.94e-06	0.000154	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—F2—coronary artery disease	4.94e-06	0.000154	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	4.92e-06	0.000153	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	4.88e-06	0.000152	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	4.84e-06	0.00015	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	4.73e-06	0.000147	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	4.64e-06	0.000144	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	4.6e-06	0.000143	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	4.6e-06	0.000143	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	4.54e-06	0.000141	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	4.5e-06	0.00014	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	4.5e-06	0.00014	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	4.5e-06	0.00014	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	4.49e-06	0.000139	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	4.43e-06	0.000138	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	4.41e-06	0.000137	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	4.41e-06	0.000137	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	4.39e-06	0.000136	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	4.33e-06	0.000135	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	4.31e-06	0.000134	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.21e-06	0.000131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	4.2e-06	0.000131	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.12e-06	0.000128	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	4.11e-06	0.000128	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	4.07e-06	0.000126	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	4.01e-06	0.000125	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	3.98e-06	0.000124	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	3.93e-06	0.000122	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	3.9e-06	0.000121	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	3.82e-06	0.000119	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	3.82e-06	0.000119	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	3.74e-06	0.000116	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	3.56e-06	0.000111	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	3.48e-06	0.000108	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	3.44e-06	0.000107	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	3.41e-06	0.000106	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	3.39e-06	0.000105	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	3.37e-06	0.000105	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	3.33e-06	0.000104	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	3.32e-06	0.000103	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	3.31e-06	0.000103	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	3.25e-06	0.000101	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	3.22e-06	0.0001	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	3.15e-06	9.79e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	3.12e-06	9.7e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	3.06e-06	9.49e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	2.89e-06	8.98e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	2.83e-06	8.79e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	2.65e-06	8.25e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	2.6e-06	8.09e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	2.6e-06	8.07e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	2.55e-06	7.91e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	2.26e-06	7.02e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	2.21e-06	6.86e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	2e-06	6.21e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	1.96e-06	6.08e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	1.85e-06	5.73e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.81e-06	5.61e-05	CbGpPWpGaD
